Impella-supported left main percutaneous coronary intervention following balloon aortic valvuloplasty: a bridge-to-TAVI strategy
Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland
Department of Cardiology, T. Marciniak Lower Silesian Specialist Hospital – Emergency Medicine Center, Wrocław, Poland
Medical University of Warsaw, Poland
Article file
- Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87-165.
- Saia F, Moretti C, Dall’Ara G, et al. Balloon aortic valvuloplasty as a bridge-to-decision in high-risk patients with aortic stenosis: a new paradigm for heart team decision-making. J Geriatr Cardiol 2016; 13: 475-82.
- O’Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126: 1717-27.
- Burzotta F, Trani C, Doshi SN, et al. Impella ventricular support in clinical practice: collaborative viewpoint from a European expert user group. Int J Cardiol 2015; 201: 684-91.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
